Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
Ennishi D, Takeuchi K, Yokoyama M, Asai H, Mishima Y, Terui Y, Takahashi S, Komatsu H, Ikeda K, Yamaguchi M, Suzuki R, Tanimoto M, Hatake K. Ennishi D, et al. Among authors: hatake k. Ann Oncol. 2008 Nov;19(11):1921-6. doi: 10.1093/annonc/mdn392. Epub 2008 Jun 23. Ann Oncol. 2008. PMID: 18573805 Free article.
Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy.
Kodaira M, Takahashi S, Yamada S, Ueda K, Mishima Y, Takeuchi K, Yamamoto N, Ishikawa Y, Yokoyama M, Saotome T, Terui Y, Hatake K. Kodaira M, et al. Among authors: hatake k. Ann Oncol. 2010 Jun;21(6):1163-1167. doi: 10.1093/annonc/mdp583. Epub 2009 Dec 17. Ann Oncol. 2010. PMID: 20019088 Free article.
High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.
Kusano Y, Yokoyama M, Terui Y, Inoue N, Takahashi A, Yamauchi H, Tsuyama N, Nishimura N, Mishima Y, Takeuchi K, Hatake K. Kusano Y, et al. Among authors: hatake k. Blood Cancer J. 2017 Sep 29;7(9):e614. doi: 10.1038/bcj.2017.96. Blood Cancer J. 2017. PMID: 28960192 Free PMC article. No abstract available.
Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.
Kodaira M, Takahashi S, Takeuchi K, Yuasa T, Saotome T, Yonese J, Fukui I, Hatake K. Kodaira M, et al. Among authors: hatake k. Ann Oncol. 2010 Jul;21(7):1563-1565. doi: 10.1093/annonc/mdq299. Ann Oncol. 2010. PMID: 20573851 Free article. No abstract available.
Lichenoid drug eruption associated with Bendamustine.
Kusano Y, Terui Y, Yokoyama M, Hatake K. Kusano Y, et al. Among authors: hatake k. Blood Cancer J. 2016 Jun 24;6(6):e438. doi: 10.1038/bcj.2016.48. Blood Cancer J. 2016. PMID: 27341077 Free PMC article. No abstract available.
471 results